Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management | Varies by plan |
| Moderate-to-severe obstructive sleep apnea in adults with obesity | Covered with prior authorization |
If your plan denies coverage, two cash programs to check.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes. Cheapest GLP-1 ranks every cash price on the chart.
Prior authorization: the plan reviews the prescription before it pays.
BCBSIL runs its drug benefit through Prime Therapeutics. What the group bought decides whether weight-management drugs are in, and many groups leave them out. Where the benefit is in, Zepbound needs the plan to sign off. The bar is a BMI of 30 or higher, or 27 or higher with a weight-related condition. You also need at least 6 months of a reduced-calorie diet, more physical activity, and work on changing habits. Zepbound is covered too for moderate to severe obstructive sleep apnea in adults with obesity. That one is reviewed as a separate medical use. This answer covers commercial plans that are not Medicare.
Source: BCBS Illinois policy Choice_Commercial_PS_Weight_Management_PAQL_ProgSum_07-01-2026_v4. Checked August 28, 2026.
Where your plan lists it. Blue Cross and Blue Shield of Illinois marks Zepbound P+ on its Performance Annual Drug List, updated June 1, 2026. P is the preferred brand code and the plus sign means the coverage is group-specific. That list covers Blue Advantage HMO and Blue Advantage Value Choice HMO. Source: Blue Cross and Blue Shield of Illinois Performance Annual Drug List. Checked September 6, 2026.
What it costs once they say yes. With commercial insurance the manufacturer savings card takes Zepbound to as little as $25 a month. Your plan sets the copay before the card applies. What Zepbound costs with your plan.
This varies by plan. BCBSIL's drug benefit runs through Prime Therapeutics. Coverage for GLP-1 and weight-loss drugs, Zepbound included, is optional, and it varies by employer group. BCBSIL says the categories and medications included may vary according to employer group selections, and that benefits are subject to the member's certificate of coverage (bcbsil.com/provider/education/education-reference/news/2024/08-12-2024-30-day-supply-limit). Prime's weight-management criteria approve the obesity use only when the patient's benefit does not restrict obesity coverage. The obstructive sleep apnea use is reviewed on its own, and it does not carry that benefit-exclusion gate. So read your own certificate of coverage before you assume you have it.
Coverage by indication
| BMI threshold | 30 or higher, or 27 or higher with at least one weight-related condition. 25 or higher for adults of South Asian, Southeast Asian, or East Asian descent |
| Step therapy | Not required |
What the prior authorization needs:
- Obesity is not restricted from coverage under the patient's benefit (employer-elected; many groups exclude anti-obesity drugs)
- Adult (18 or older) with BMI 30 or higher, or 27 or higher with a weight-related condition such as hypertension, type 2 diabetes, obstructive sleep apnea, cardiovascular disease, or dyslipidemia (25 or higher for South, Southeast, or East Asian descent)
- At least 6 months on a reduced-calorie diet, increased physical activity, and behavioral modification, continued alongside the drug
- No formal step through Wegovy. The criteria require that no targeted weight-loss drug was tried in the past 12 months. Those drugs are Saxenda, Wegovy and Zepbound. A prescriber who expects a repeat course to work can state that instead.
- Not used in combination with another GLP-1 receptor agonist or other weight-loss drug
- No FDA-labeled contraindication (for example personal or family history of medullary thyroid carcinoma or MEN 2)
- A quantity limit applies. For example 4 pens or 4 vials per 28 days, and 4 of the 2.5 mg starter per 180 days. The first approval runs 12 months. To renew you need 5% or more weight loss, or you have to be under 52 weeks on the highest dose you can take.
Source: BCBS Illinois policy Choice_Commercial_PS_Weight_Management_PAQL_ProgSum_07-01-2026_v4. The pharmacy benefit manager's policy.
| BMI threshold | 30 or higher |
| Step therapy | Not required |
What the prior authorization needs:
- Diagnosis of obstructive sleep apnea confirmed by polysomnography or a home sleep apnea test
- An apnea-hypopnea index (AHI) of 15 or higher events an hour at the start, before any drug therapy
- BMI 30 or higher
- On a reduced-calorie diet, with more physical activity and work on changing habits, kept up while on the drug
- Not used in combination with another GLP-1 receptor agonist; no FDA-labeled contraindication
- Reviewed as an FDA-approved medical use of its own, so the obesity benefit exclusion does not gate it. The first approval runs 12 months. To renew you need a written record of clinical benefit, such as a lower AHI.
Source: BCBS Illinois policy Choice_Commercial_PS_Weight_Management_PAQL_ProgSum_07-01-2026_v4. The pharmacy benefit manager's policy.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- Your plan may treat another GLP-1 differently. The BCBS Illinois coverage check lists all 5, with the source for each.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does BCBS Illinois cover Zepbound?
Yes on some plans. BCBSIL runs its drug benefit through Prime Therapeutics. What the group bought decides whether weight-management drugs are in, and many groups leave them out. Where the benefit is in, Zepbound needs the plan to sign off. The bar is a BMI of 30 or higher, or 27 or higher with a weight-related condition. You also need at least 6 months of a reduced-calorie diet, more physical activity, and work on changing habits. Zepbound is covered too for moderate to severe obstructive sleep apnea in adults with obesity. That one is reviewed as a separate medical use. Policy checked August 2026.
What does BCBS Illinois require to approve Zepbound?
For moderate-to-severe obstructive sleep apnea in adults with obesity: The BMI requirement is 30 or higher.
Why might BCBS Illinois deny Zepbound even if I meet the criteria?
BCBSIL's drug benefit runs through Prime Therapeutics. Coverage for GLP-1 and weight-loss drugs, Zepbound included, is optional, and it varies by employer group. BCBSIL says the categories and medications included may vary according to employer group selections, and that benefits are subject to the member's certificate of coverage (bcbsil.com/provider/education/education-reference/news/2024/08-12-2024-30-day-supply-limit). Prime's weight-management criteria approve the obesity use only when the patient's benefit does not restrict obesity coverage. The obstructive sleep apnea use is reviewed on its own, and it does not carry that benefit-exclusion gate. So read your own certificate of coverage before you assume you have it.
Does BCBS Illinois cover Zepbound for sleep apnea?
Yes, with prior authorization. BCBS Illinois states this in Weight Management Prior Authorization with Quantity Limit Program Summary (Prime Therapeutics, effective 07-01-2026), read August 2026.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
